NCT00801086 - Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

June 30, 2010

Conditions

Alopecia

Interventions

DRUG

7% (w/v) Tempol alcohol-based gel (MTS-01)

200mL gel applied daily prior to radiation dose and removed immediately thereafter.

DRUG

alcohol-based gel

200mL gel applied daily prior to radiation dose and removed immediately thereafter

Trial Locations (2)

RECRUITING

University of Pennsylvania, Philadelphia

RECRUITING

University of Arizona, Tucson